Position in GILD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$8,885,744
-$912,803 QoQ
Shares Held
70,332
+0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#452
of 2,266 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026THOMPSON SIEGEL & WALMSLEY LLC holds $141,170,482 across 11 Drug Manufacturers - General names. GILD ranks #7 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
274,133 | $35,226,090 | |
| 2 | BIIB |
Biogen Inc.
|
130,512 | $28,198,422 | |
| 3 | ABBV |
AbbVie Inc.
|
72,426 | $18,225,278 | |
| 4 | PFE |
Pfizer Inc
|
589,575 | $14,196,966 | |
| 5 | AMGN |
Amgen Inc
|
34,760 | $12,587,291 | |
| 6 | JNJ |
Johnson & Johnson
|
41,916 | $10,645,406 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
70,332 | $8,885,744 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
121,984 | $7,028,718 |
All Filings in GILD
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,885,744 | 70,332 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $9,798,547 | 70,306 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $8,629,358 | 70,306 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $6,139,521 | 55,311 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $6,132,884 | 55,316 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $9,030,221 | 80,591 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $10,279,949 | 111,291 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $9,331,811 | 111,305 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $4,623,216 | 67,384 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $4,929,725 | 67,300 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $5,451,973 | 67,300 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $5,982,085 | 79,825 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $7,676,172 | 99,600 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $8,321,891 | 100,300 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $9,898,505 | 115,300 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $6,434,267 | 104,300 | Shares | Defined | 2022-10-25 | |
| 2022-06-30 | $3,665,333 | 59,300 | Shares | Defined | 2022-07-22 | |
| 2020-09-30 | $55,164 | 873 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $632,215 | 8,217 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $9,646,581 | 129,034 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||